| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8485648 | Vaccine | 2018 | 10 Pages |
Abstract
Antibody persistence (rSBA titersâ¯â¥â¯1:8) for serogroups A, W and Y was observed in more than 50.0% of the children 68â¯M after receiving one dose of MenACWY-TT; for MenC, antibody persistence was observed in more than one third of MenACWY-TT and more than half of MenC-CRM197 recipients. Vaccination with a booster dose of MenACWY-TT induced robust immune responses for all serogroups.
Keywords
meningococcal serogroup BCISmenBTVCIMDMenACWY-TThSBArSBAGMTsSAEsAesATPaccording-to-protocolInvasive meningococcal diseaseAntibody persistencetetanus toxoidGastrointestinalAdverse eventsserious adverse eventsconfidence intervalsMonthMencgeometric mean titersQuadrivalent meningococcal vaccineConjugate vaccineBooster responsetotal vaccinated cohortChildren
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Markus Knuf, Klaus Helm, Devayani Kolhe, Marie Van Der Wielen, Yaela Baine,